169 related articles for article (PubMed ID: 1724122)
1. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
Swenson CL; Polas PJ; Cheney CM; Kociba GJ; Mathes LE
Am J Vet Res; 1991 Dec; 52(12):2010-5. PubMed ID: 1724122
[TBL] [Abstract][Full Text] [Related]
2. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
3. Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats.
Hoover EA; Olsen RG; Mathes LE; Schaller JP
Cancer Res; 1977 Oct; 37(10):3707-10. PubMed ID: 198120
[TBL] [Abstract][Full Text] [Related]
4. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
5. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
[TBL] [Abstract][Full Text] [Related]
6. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
Lizonová A; Grófová M
Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells.
Rojko JL; Fulton RM; Rezanka LJ; Williams LL; Copelan E; Cheney CM; Reichel GS; Neil JC; Mathes LE; Fisher TG
Lab Invest; 1992 Apr; 66(4):418-26. PubMed ID: 1349933
[TBL] [Abstract][Full Text] [Related]
8. Effect of type I interferons on the expression of feline leukaemia virus.
Collado VM; Gómez-Lucía E; Tejerizo G; Miró G; Escolar E; Martín S; Doménech A
Vet Microbiol; 2007 Jul; 123(1-3):180-6. PubMed ID: 17507184
[TBL] [Abstract][Full Text] [Related]
9. Phosphonoformate inhibits reverse transcriptase.
Sundquist B; Oberg B
J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
[TBL] [Abstract][Full Text] [Related]
10. Induction of Epstein-Barr virus antigens and DNA-polymerase activities in P3HR-1 cell line and its subline passaged in the presence of phosphonoformate.
Prachová K; Roubal J; Vonka V; Brichácek B; Reifová M
Acta Virol; 1983 Jul; 27(4):329-36. PubMed ID: 6138996
[TBL] [Abstract][Full Text] [Related]
11. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats.
Gomes-Keller MA; Tandon R; Gönczi E; Meli ML; Hofmann-Lehmann R; Lutz H
Vet Microbiol; 2006 Jan; 112(1):11-21. PubMed ID: 16303261
[TBL] [Abstract][Full Text] [Related]
12. The location in cartilage of infectious retrovirus in cats infected with feline leukemia virus.
Arnoczky SP; Swenson C; Egerbacher M; Gardner K; Caballero O; Burns M
J Bone Joint Surg Am; 2007 Sep; 89(9):2030-6. PubMed ID: 17768202
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
14. Effect of 17beta-estradiol and progesterone on the expression of FeLV in chronically infected cells.
Tejerizo G; Domenech A; Illera JC; Collado VM; Gomez-Lucia E
Vet Microbiol; 2005 Aug; 109(3-4):191-9. PubMed ID: 16023797
[TBL] [Abstract][Full Text] [Related]
15. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line.
Burns CC; Moser M; Banks J; Alderete JP; Overbaugh J
Virology; 1996 Aug; 222(1):14-20. PubMed ID: 8806483
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of feline leukemia virus provirus integration into feline genomic DNA.
Cattori V; Tandon R; Pepin A; Lutz H; Hofmann-Lehmann R
Mol Cell Probes; 2006; 20(3-4):172-81. PubMed ID: 16488115
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model.
Polas PJ; Swenson CL; Sams R; Cheney CM; Hayes KA; Tarr MJ; Kociba GJ; Mathes LE
Antimicrob Agents Chemother; 1990 Jul; 34(7):1414-21. PubMed ID: 2167039
[TBL] [Abstract][Full Text] [Related]
18. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.
Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R
Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224
[TBL] [Abstract][Full Text] [Related]
19. Infection of feline embryo adherent cells with feline leukemia virus: feline oncornavirus-associated cell membrane antigen expression and morphologic transformation.
Rice JB; Schaller JP; Lewis MG; Mathes LE; Hoover EA; Olsen RG
J Natl Cancer Inst; 1981 Jan; 66(1):89-96. PubMed ID: 6256575
[TBL] [Abstract][Full Text] [Related]
20. Establishment of two canine sarcoma cell lines: productive infection with feline leukemia virus.
Chapman AL; Fischinger PJ; Tung HN
J Natl Cancer Inst; 1975 Aug; 55(2):345-52. PubMed ID: 169374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
